Parallax Volatility Advisers’s Aegerion Pharmaceuticals AEGR Stock Holding History

Parallax Volatility Advisers’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,671	Closed	-$56K	–	6328
2014 Q3	$56K	Buy	+1,671	New	+$51.9K	﹤0.01%	3242

Parallax Volatility Advisers's AEGR Position: Q4 2014 in Review

Parallax Volatility Advisers sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 1,671 shares — an estimated $56K sold.

Parallax Volatility Advisers first reported a position in AEGR in Q3 2014 and held it in 1 quarter. The position peaked at $56K in Q3 2014. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

Parallax Volatility Advisers reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Parallax Volatility Advisers sold 1,671 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $56K.
Parallax Volatility Advisers first reported a position in Aegerion Pharmaceuticals in Q3 2014 and held it in 1 quarter.
Parallax Volatility Advisers's Aegerion Pharmaceuticals position peaked at $56K in Q3 2014.
95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Parallax Volatility Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.